DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Gnant M, Pfeiler G, Steger GG. et al.
Austrian Breast and Colorectal Cancer Study Group. Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol 2019;
20 (03) 339-351
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.